(Theme 2) The role of antibody in COVID-19 disease: distinguishing disease enhancing and prtective immune responses.
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-354
Grant search
Key facts
Disease
COVID-19Funder
UK Research and Innovation (UKRI)Principal Investigator
Michael LevinResearch Location
United KingdomLead Research Institution
Francis Crick InstituteResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The emergence of rare but debilitating conditions associated with SARS-CoV-2 - including Paediatric Inflammatory Multisystem Syndrome (PIMS) or Kawasaki disease (KD) - has raised concern that antibodies may enhance disease. In this project, researchers aim to assess how cross-reactive antibodies against other coronaviruses cause severe disease, how do antibody responses differ between patients with asymptomatic/mild infections and severe disease and how antibodies influence the rest of the immune response.